Literature DB >> 9403752

Circulating complement proteins in multiple trauma patients--correlation with injury severity, development of sepsis, and outcome.

F Hecke1, U Schmidt, A Kola, W Bautsch, A Klos, J Köhl.   

Abstract

OBJECTIVE: To investigate protein complement 3a (C3a) and protein complement 3 (C3) plasma levels in trauma patients directly after the injury, in relation to the patients' outcome, the development of sepsis, or the injury severity, as determined by either the Polytrauma Score (PTS), the Injury Severity Score (ISS), or the Trauma and Injury Severity Score (TRISS).
DESIGN: Prospective study.
SETTING: Surgical intensive care unit in a university hospital. PATIENTS: Thirty-four patients with multiple trauma.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: C3a and C3 concentrations, as well as the C3a/C3 ratio, were determined at the time of the accident (T0), at the emergency admission (T1), 8 hrs after the accident (T2), and every 8 hrs until day 3, every 12 hrs until day 6, and once daily on days 7 and 8. The C3a plasma concentrations and the C3a/C3 ratios of nonsurvivors were significantly greater at T0 or T1 as compared with those survivors (p = .008 or .033). Patients who developed sepsis had higher C3a plasma levels at the scene of accident than patients without complications. However, these differences did not reach statistical significance (p = .051), although a clear trend was apparent. Patients were grouped according to the severity of injury, as determined by either the PTS, ISS, or TRISS. We found significant differences in the both the mean C3a values and the C3a/C3 ratio among the different groups, during the first 8 hrs after the injury. In addition, a significant correlation was observed between the C3a concentration or the C3a/C3 ratio at T0 to T2 and either the ISS (r2 = .49), PTS (r2 = .22) or the TRISS (r2 = .45), which was similar to correlations between injury severity scores themselves (r2 = .36 to .58).
CONCLUSIONS: Complement activation occurs immediately after the injury. The degree of activation is a hallmark for the outcome of a patient. Determination of C3a concentrations, at the scene of the accident, may prove helpful to assess the severity of the injury and to determine the prognosis. The amount of C3a and the C3a/C3 ratio may be useful as additional parameters to the existing trauma scoring systems, such as, PTS, ISS, and TRISS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9403752     DOI: 10.1097/00003246-199712000-00019

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  44 in total

1.  Early complementopathy after multiple injuries in humans.

Authors:  Anne-Maud Burk; Myriam Martin; Michael A Flierl; Daniel Rittirsch; Matthias Helm; Lorenz Lampl; Uwe Bruckner; Gregory L Stahl; Anna M Blom; Mario Perl; Florian Gebhard; Markus Huber-Lang
Journal:  Shock       Date:  2012-04       Impact factor: 3.454

2.  Molecular intercommunication between the complement and coagulation systems.

Authors:  Umme Amara; Michael A Flierl; Daniel Rittirsch; Andreas Klos; Hui Chen; Barbara Acker; Uwe B Brückner; Bo Nilsson; Florian Gebhard; John D Lambris; Markus Huber-Lang
Journal:  J Immunol       Date:  2010-09-24       Impact factor: 5.422

Review 3.  Interaction between the coagulation and complement system.

Authors:  Umme Amara; Daniel Rittirsch; Michael Flierl; Uwe Bruckner; Andreas Klos; Florian Gebhard; John D Lambris; Markus Huber-Lang
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 4.  Interactions between coagulation and complement--their role in inflammation.

Authors:  Katerina Oikonomopoulou; Daniel Ricklin; Peter A Ward; John D Lambris
Journal:  Semin Immunopathol       Date:  2011-08-03       Impact factor: 9.623

Review 5.  Postinjury Inflammation and Organ Dysfunction.

Authors:  Angela Sauaia; Frederick A Moore; Ernest E Moore
Journal:  Crit Care Clin       Date:  2017-01       Impact factor: 3.598

Review 6.  TACTIC: Trans-Agency Consortium for Trauma-Induced Coagulopathy.

Authors:  K G Mann; K Freeman
Journal:  J Thromb Haemost       Date:  2015-06       Impact factor: 5.824

7.  APT070 (Mirococept), a membrane-localised complement inhibitor, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury.

Authors:  Danielle G Souza; Dirk Esser; Roberta Bradford; Angélica T Vieira; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

8.  C5aR-antagonist significantly reduces the deleterious effect of a blunt chest trauma on fracture healing.

Authors:  Stefan Recknagel; Ronny Bindl; Julian Kurz; Tim Wehner; Philipp Schoengraf; Christian Ehrnthaller; Hongchang Qu; Florian Gebhard; Markus Huber-Lang; John D Lambris; Lutz Claes; Anita Ignatius
Journal:  J Orthop Res       Date:  2011-09-15       Impact factor: 3.494

9.  Protective Effects of the Complement Inhibitor Compstatin CP40 in Hemorrhagic Shock.

Authors:  Martijn van Griensven; Daniel Ricklin; Stephanie Denk; Rebecca Halbgebauer; Christian K Braun; Anke Schultze; Felix Hönes; Sofia Koutsogiannaki; Alexandra Primikyri; Edimara Reis; David Messerer; Sebastian Hafner; Peter Radermacher; Ali-Reza Biglarnia; Ranillo R G Resuello; Joel V Tuplano; Benjamin Mayer; Kristina Nilsson; Bo Nilsson; John D Lambris; Markus Huber-Lang
Journal:  Shock       Date:  2019-01       Impact factor: 3.454

10.  Complement mediates a primed inflammatory response after traumatic lung injury.

Authors:  J Jason Hoth; Jonathan D Wells; Sarah E Jones; Barbara K Yoza; Charles E McCall
Journal:  J Trauma Acute Care Surg       Date:  2014-03       Impact factor: 3.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.